Previous Article | Next Article 
Journal of Clinical Microbiology, August 2008, p. 2659-2664, Vol. 46, No. 8
0095-1137/08/$08.00+0 doi:10.1128/JCM.00803-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis
Shawn R. Lockhart,1*
Shawn A. Messer,1
Michael A. Pfaller,1 and
Daniel J. Diekema1,2
Departments of Pathology,1
Internal Medicine, University of Iowa Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa2
Received 28 April 2008/
Returned for modification 5 June 2008/
Accepted 10 June 2008
Candida orthopsilosis and Candida metapsilosis are recently described species, having previously been grouped with the more prevalent species Candida parapsilosis. Current literature contains very little data pertaining to the distributions and antifungal susceptibilities of these Candida species. We determined the species and antifungal susceptibilities of 1,929 invasive clinical isolates from the ARTEMIS antifungal surveillance program collected between 2001 and 2006 and identified as C. parapsilosis using Vitek and conventional methods. Of the 1,929 isolates of presumed C. parapsilosis tested, 117 (6.1%) were identified as C. orthopsilosis and 34 (1.8%) as C. metapsilosis. The percentage of presumed C. parapsilosis isolates found to be C. orthopsilosis varied greatly by region, with the highest percentage (10.9%) from South America and the lowest (0.7%) from Africa. The MIC distributions of the C. orthopsilosis and C. metapsilosis isolates were statistically significantly lower than those of C. parapsilosis for all drugs except fluconazole, for which they were significantly higher (P < 0.001 for all). No C. orthopsilosis or C. metapsilosis isolates were fluconazole resistant, and all were susceptible to caspofungin, anidulafungin, and micafungin.
* Corresponding author. Mailing address: Department of Pathology, University of Iowa Hospitals and Clinics, 6008 BT GH, 200 Hawkins Drive, Iowa City, IA 52242-1009. Phone: (319) 356-2104. Fax: (319) 356-4916. E-mail:
shawn-lockhart{at}uiowa.edu
Published ahead of print on 18 June 2008.
Journal of Clinical Microbiology, August 2008, p. 2659-2664, Vol. 46, No. 8
0095-1137/08/$08.00+0 doi:10.1128/JCM.00803-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Diekema, D. J., Messer, S. A., Boyken, L. B., Hollis, R. J., Kroeger, J., Tendolkar, S., Pfaller, M. A.
(2009). In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods. J. Clin. Microbiol.
47: 3170-3177
[Abstract]
[Full Text]
-
Marklein, G., Josten, M., Klanke, U., Muller, E., Horre, R., Maier, T., Wenzel, T., Kostrzewa, M., Bierbaum, G., Hoerauf, A., Sahl, H.-G.
(2009). Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Fast and Reliable Identification of Clinical Yeast Isolates. J. Clin. Microbiol.
47: 2912-2917
[Abstract]
[Full Text]
-
Silva, A. P., Miranda, I. M., Lisboa, C., Pina-Vaz, C., Rodrigues, A. G.
(2009). Prevalence, Distribution, and Antifungal Susceptibility Profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a Tertiary Care Hospital. J. Clin. Microbiol.
47: 2392-2397
[Abstract]
[Full Text]
-
Borman, A. M., Linton, C. J., Oliver, D., Palmer, M. D., Szekely, A., Odds, F. C., Johnson, E. M.
(2009). Pyrosequencing Analysis of 20 Nucleotides of Internal Transcribed Spacer 2 Discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis. J. Clin. Microbiol.
47: 2307-2310
[Abstract]
[Full Text]
-
Asadzadeh, M., Ahmad, S., Al-Sweih, N., Khan, Z. U.
(2009). Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait. J Med Microbiol
58: 745-752
[Abstract]
[Full Text]
-
Lockhart, S. R., Messer, S. A., Pfaller, M. A., Diekema, D. J.
(2009). Identification and Susceptibility Profile of Candida fermentati from a Worldwide Collection of Candida guilliermondii Clinical Isolates. J. Clin. Microbiol.
47: 242-244
[Abstract]
[Full Text]
-
Varga, I., Soczo, G., Kardos, G., Borbely, A., Szabo, Zs., Kemeny-Beke, A., Majoros, L.
(2008). Comparison of killing activity of caspofungin against Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis. J Antimicrob Chemother
62: 1466-1468
[Full Text]